Latest Daily Edition Stories
The lawsuit alleges that Sutter and Palo Alto Medical intentionally submitted inaccurate diagnosis codes that inflated so-called risk scores given to patients.
Rose and Allen Nelson were promised that the treatment facility where their son was getting mental health help would provide a top of the line team. After Brandon’s suicide, they’re trying to figure out what went wrong.
California Medical Association, which has 43,000 members, weighed in on the proposed policy from President Donald Trump that would penalize legal immigrants who are seeking green cards for receiving government aid such as Medicaid. “Discouraging participation in Medi-Cal (Medicaid) could result in coverage losses throughout California, decreased access to care, and worse health outcomes for entire families, including children, many of whom are U.S. citizens,” wrote Dr. David H. Aizuss, CMA president.
The merger between the health systems cleared its last major regulatory hurdle when the California Department of Justice issued conditional approval the day before Thanksgiving. Dignity leaders said final closure is expected on Dec. 31.
Some non-urgent mental health and other appointments may need to be rescheduled, but anyone in need of urgent mental health or other health care will receive the services they need, said Elita Fielder, a spokeswoman for Kaiser Permanente.
“This strike is a clear message to Kaiser that its mental health clinicians won’t stand by silently while their patients can’t get the care they need,” union leader Sal Rosselli said in a statement. Kaiser claims the union is most interested in raising wages that are already among the best in the nation.
The therapies include risks and work for only a minority of patients. But those successes continue to drive the research forward.
A Swiss drugmaker is challenging a 2011 change to the law that no longer allows a company to patent an invention if it was for sale for more than a year before filing a patent application. Meanwhile, Congress also plans to focus on the issue of pharmaceutical patents and lawmakers continue to question the industry’s pricing decisions. And as Capitol Hill gears up for potential action on drug costs, there may be some lessons to be learned from China.
The Justice Department alleged that Actelion Pharmaceuticals violated federal law by using a foundation fund to funnel kickback payments aimed at inducing patients to buy its drugs. Actelion was bought by Johnson & Johnson in 2017, after the alleged actions took place, and admits no wrongdoing as part of the settlement. And in other pharma news: Walgreens’ new delivery service; an EpiPen alternative; and the FDA approves a new lung cancer treatment.
The Obama administration’s regulation was a target for rural landowners since it could have restricted how much pollution from chemical fertilizers and pesticides could seep into water. In other national news, the surgeon general acknowledges the need for changes in the classification of drugs, the Trump administration requests more funding for immigrant detention efforts and Maine’s outgoing governor loses another skirmish in his efforts to stop Medicaid expansion.